Skip to main content
Thorax logoLink to Thorax
. 1992 Nov;47(11):979–983. doi: 10.1136/thx.47.11.979

Bradykinin and asthma.

P J Barnes 1
PMCID: PMC464122  PMID: 1465760

Full text

PDF
979

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker A. P., Hillegass L. M., Holden D. A., Smith W. J. Effect of kallidin, substance P, and other basic polypeptides on the production of respiratory macromolecules. Am Rev Respir Dis. 1977 May;115(5):811–817. doi: 10.1164/arrd.1977.115.5.811. [DOI] [PubMed] [Google Scholar]
  2. Baraniuk J. N., Lundgren J. D., Mizoguchi H., Peden D., Gawin A., Merida M., Shelhamer J. H., Kaliner M. A. Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo. Am Rev Respir Dis. 1990 Mar;141(3):706–714. doi: 10.1164/ajrccm/141.3.706. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. J., Chung K. F., Page C. P. Inflammatory mediators and asthma. Pharmacol Rev. 1988 Mar;40(1):49–84. [PubMed] [Google Scholar]
  4. Braas K. M., Manning D. C., Perry D. C., Snyder S. H. Bradykinin analogues: differential agonist and antagonist activities suggesting multiple receptors. Br J Pharmacol. 1988 May;94(1):3–5. doi: 10.1111/j.1476-5381.1988.tb11492.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bramley A. M., Samhoun M. N., Piper P. J. The role of the epithelium in modulating the responses of guinea-pig trachea induced by bradykinin in vitro. Br J Pharmacol. 1990 Apr;99(4):762–766. doi: 10.1111/j.1476-5381.1990.tb13003.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burch R. M., Farmer S. G., Steranka L. R. Bradykinin receptor antagonists. Med Res Rev. 1990 Apr-Jun;10(2):237–269. doi: 10.1002/med.2610100204. [DOI] [PubMed] [Google Scholar]
  7. Choudry N. B., Fuller R. W., Pride N. B. Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. Am Rev Respir Dis. 1989 Jul;140(1):137–141. doi: 10.1164/ajrccm/140.1.137. [DOI] [PubMed] [Google Scholar]
  8. Christiansen S. C., Proud D., Cochrane C. G. Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J Clin Invest. 1987 Jan;79(1):188–197. doi: 10.1172/JCI112782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Christiansen S. C., Proud D., Sarnoff R. B., Juergens U., Cochrane C. G., Zuraw B. L. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):900–905. doi: 10.1164/ajrccm/145.4_Pt_1.900. [DOI] [PubMed] [Google Scholar]
  10. Corfield D. R., Webber S. E., Hanafi Z., Widdicombe J. G. The actions of bradykinin and lys-bradykinin on tracheal blood flow and smooth muscle in anaesthetized sheep. Pulm Pharmacol. 1991;4(2):85–90. doi: 10.1016/0952-0600(91)90057-a. [DOI] [PubMed] [Google Scholar]
  11. Dixon C. M., Fuller R. W., Barnes P. J. The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects. Br J Clin Pharmacol. 1987 Jan;23(1):91–93. doi: 10.1111/j.1365-2125.1987.tb03015.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dixon M., Jackson D. M., Richards I. M. The effects of sodium cromoglycate on lung irritant receptors and left ventricular cardiac receptors in the anaesthetized dog. Br J Pharmacol. 1979 Dec;67(4):569–574. doi: 10.1111/j.1476-5381.1979.tb08703.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dusser D. J., Nadel J. A., Sekizawa K., Graf P. D., Borson D. B. Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret trachea. J Pharmacol Exp Ther. 1988 Feb;244(2):531–536. [PubMed] [Google Scholar]
  14. Evans D., Levison M. J., Feldman C. H., Clark N. M., Wasilewski Y., Levin B., Mellins R. B. The impact of passive smoking on emergency room visits of urban children with asthma. Am Rev Respir Dis. 1987 Mar;135(3):567–572. doi: 10.1164/arrd.1987.135.3.567. [DOI] [PubMed] [Google Scholar]
  15. Farmer S. G., Burch R. M., Kyle D. J., Martin J. A., Meeker S. N., Togo J. D-Arg[Hyp3-Thi5-D-Tic7-Tic8]-bradykinin, a potent antagonist of smooth muscle BK2 receptors and BK3 receptors. Br J Pharmacol. 1991 Apr;102(4):785–787. doi: 10.1111/j.1476-5381.1991.tb12251.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Farmer S. G., Burch R. M., Meeker S. A., Wilkins D. E. Evidence for a pulmonary B3 bradykinin receptor. Mol Pharmacol. 1989 Jul;36(1):1–8. [PubMed] [Google Scholar]
  17. Farmer S. G., Ensor J. E., Burch R. M. Evidence that cultured airway smooth muscle cells contain bradykinin B2 and B3 receptors. Am J Respir Cell Mol Biol. 1991 Mar;4(3):273–277. doi: 10.1165/ajrcmb/4.3.273. [DOI] [PubMed] [Google Scholar]
  18. Frossard N., Stretton C. D., Barnes P. J. Modulation of bradykinin responses in airway smooth muscle by epithelial enzymes. Agents Actions. 1990 Nov;31(3-4):204–209. doi: 10.1007/BF01997609. [DOI] [PubMed] [Google Scholar]
  19. Fuller R. W. Cough associated with angiotensin-converting enzyme inhibitors. J Hum Hypertens. 1989 Jun;3 (Suppl 1):159–161. [PubMed] [Google Scholar]
  20. Fuller R. W., Dixon C. M., Cuss F. M., Barnes P. J. Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis. 1987 Jan;135(1):176–180. doi: 10.1164/arrd.1987.135.1.176. [DOI] [PubMed] [Google Scholar]
  21. Hock F. J., Wirth K., Albus U., Linz W., Gerhards H. J., Wiemer G., Henke S., Breipohl G., König W., Knolle J. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol. 1991 Mar;102(3):769–773. doi: 10.1111/j.1476-5381.1991.tb12248.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ichinose M., Barnes P. J. A potassium channel activator modulates both excitatory noncholinergic and cholinergic neurotransmission in guinea pig airways. J Pharmacol Exp Ther. 1990 Mar;252(3):1207–1212. [PubMed] [Google Scholar]
  23. Ichinose M., Barnes P. J. Bradykinin-induced airway microvascular leakage and bronchoconstriction are mediated via a bradykinin B2 receptor. Am Rev Respir Dis. 1990 Nov;142(5):1104–1107. doi: 10.1164/ajrccm/142.5.1104. [DOI] [PubMed] [Google Scholar]
  24. Ichinose M., Barnes P. J. The effect of peptidase inhibitors on bradykinin-induced bronchoconstriction in guinea-pigs in vivo. Br J Pharmacol. 1990 Sep;101(1):77–80. doi: 10.1111/j.1476-5381.1990.tb12092.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jackson D. M., Norris A. A., Eady R. P. Nedocromil sodium and sensory nerves in the dog lung. Pulm Pharmacol. 1989;2(4):179–184. doi: 10.1016/0952-0600(89)90018-5. [DOI] [PubMed] [Google Scholar]
  26. Jin L. S., Seeds E., Page C. P., Schachter M. Inhibition of bradykinin-induced bronchoconstriction in the guinea-pig by a synthetic B2 receptor antagonist. Br J Pharmacol. 1989 Jun;97(2):598–602. doi: 10.1111/j.1476-5381.1989.tb11991.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kaufman M. P., Coleridge H. M., Coleridge J. C., Baker D. G. Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs. J Appl Physiol Respir Environ Exerc Physiol. 1980 Mar;48(3):511–517. doi: 10.1152/jappl.1980.48.3.511. [DOI] [PubMed] [Google Scholar]
  28. Leikauf G. D., Ueki I. F., Nadel J. A., Widdicombe J. H. Bradykinin stimulates Cl secretion and prostaglandin E2 release by canine tracheal epithelium. Am J Physiol. 1985 Jan;248(1 Pt 2):F48–F55. doi: 10.1152/ajprenal.1985.248.1.F48. [DOI] [PubMed] [Google Scholar]
  29. Lötvall J. O., Tokuyama K., Löfdahl C. G., Ullman A., Barnes P. J., Chung K. F. Peptidase modulation of noncholinergic vagal bronchoconstriction and airway microvascular leakage. J Appl Physiol (1985) 1991 Jun;70(6):2730–2735. doi: 10.1152/jappl.1991.70.6.2730. [DOI] [PubMed] [Google Scholar]
  30. Mak J. C., Barnes P. J. Autoradiographic visualization of bradykinin receptors in human and guinea pig lung. Eur J Pharmacol. 1991 Feb 26;194(1):37–43. doi: 10.1016/0014-2999(91)90121-6. [DOI] [PubMed] [Google Scholar]
  31. McEachern A. E., Shelton E. R., Bhakta S., Obernolte R., Bach C., Zuppan P., Fujisaki J., Aldrich R. W., Jarnagin K. Expression cloning of a rat B2 bradykinin receptor. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7724–7728. doi: 10.1073/pnas.88.17.7724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. McEwan J. R., Choudry N. B., Fuller R. W. The effect of sulindac on the abnormal cough reflex associated with dry cough. J Pharmacol Exp Ther. 1990 Oct;255(1):161–164. [PubMed] [Google Scholar]
  33. Nadel J. A. Neutral endopeptidase modulates neurogenic inflammation. Eur Respir J. 1991 Jun;4(6):745–754. [PubMed] [Google Scholar]
  34. Nakanishi S. Substance P precursor and kininogen: their structures, gene organizations, and regulation. Physiol Rev. 1987 Oct;67(4):1117–1142. doi: 10.1152/physrev.1987.67.4.1117. [DOI] [PubMed] [Google Scholar]
  35. Parsons G. H., Nichol G. M., Barnes P. J., Chung K. F. Peptide mediator effects on bronchial blood velocity and lung resistance in conscious sheep. J Appl Physiol (1985) 1992 Mar;72(3):1118–1122. doi: 10.1152/jappl.1992.72.3.1118. [DOI] [PubMed] [Google Scholar]
  36. Polosa R., Holgate S. T. Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9]bradykinin in normal and asthmatic subjects. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1367–1371. doi: 10.1164/ajrccm/142.6_Pt_1.1367. [DOI] [PubMed] [Google Scholar]
  37. Polosa R., Phillips G. D., Lai C. K., Holgate S. T. Contribution of histamine and prostanoids to bronchoconstriction provoked by inhaled bradykinin in atopic asthma. Allergy. 1990 Apr;45(3):174–182. doi: 10.1111/j.1398-9995.1990.tb00480.x. [DOI] [PubMed] [Google Scholar]
  38. Pongracic J. A., Naclerio R. M., Reynolds C. J., Proud D. A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin. Br J Clin Pharmacol. 1991 Mar;31(3):287–294. doi: 10.1111/j.1365-2125.1991.tb05532.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Proud D., Kaplan A. P. Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol. 1988;6:49–83. doi: 10.1146/annurev.iy.06.040188.000405. [DOI] [PubMed] [Google Scholar]
  40. Proud D., Siekierski E. S., Bailey G. S. Identification of human lung mast cell kininogenase as tryptase and relevance of tryptase kininogenase activity. Biochem Pharmacol. 1988 Apr 15;37(8):1473–1480. doi: 10.1016/0006-2952(88)90008-1. [DOI] [PubMed] [Google Scholar]
  41. Ray N. J., Jones A. J., Keen P. Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro. Br J Pharmacol. 1991 Apr;102(4):797–800. doi: 10.1111/j.1476-5381.1991.tb12254.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980 Mar;32(1):1–46. [PubMed] [Google Scholar]
  43. Regoli D., Drapeau G., Rovero P., Dion S., Rhaleb N. E., Barabé J., D'Orléans-Juste P., Ward P. Conversion of kinins and their antagonists into B1 receptor activators and blockers in isolated vessels. Eur J Pharmacol. 1986 Aug 15;127(3):219–224. doi: 10.1016/0014-2999(86)90367-5. [DOI] [PubMed] [Google Scholar]
  44. Rogers D. F., Dijk S., Barnes P. J. Bradykinin-induced plasma exudation in guinea-pig airways: involvement of platelet activating factor. Br J Pharmacol. 1990 Nov;101(3):739–745. doi: 10.1111/j.1476-5381.1990.tb14150.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sakamoto T., Elwood W., Barnes P. J., Chung K. F. Effect of Hoe 140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factor-induced bronchoconstriction and airway microvascular leakage in guinea pig. Eur J Pharmacol. 1992 Mar 31;213(3):367–373. doi: 10.1016/0014-2999(92)90625-e. [DOI] [PubMed] [Google Scholar]
  46. Saria A., Martling C. R., Yan Z., Theodorsson-Norheim E., Gamse R., Lundberg J. M. Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am Rev Respir Dis. 1988 Jun;137(6):1330–1335. doi: 10.1164/ajrccm/137.6.1330. [DOI] [PubMed] [Google Scholar]
  47. Simonsson B. G., Skoogh B. E., Bergh N. P., Andersson R., Svedmyr N. In vivo and in vitro effect of bradykinin on bronchial motor tone in normal subjects and patients with airways obstruction. Respiration. 1973;30(4):378–388. doi: 10.1159/000193051. [DOI] [PubMed] [Google Scholar]
  48. Solèr M., Sielczak M., Abraham W. M. A bradykinin-antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. Pulm Pharmacol. 1990;3(1):9–15. doi: 10.1016/0952-0600(90)90003-2. [DOI] [PubMed] [Google Scholar]
  49. Steranka L. R., Manning D. C., DeHaas C. J., Ferkany J. W., Borosky S. A., Connor J. R., Vavrek R. J., Stewart J. M., Snyder S. H. Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci U S A. 1988 May;85(9):3245–3249. doi: 10.1073/pnas.85.9.3245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Vavrek R. J., Stewart J. M. Competitive antagonists of bradykinin. Peptides. 1985 Mar-Apr;6(2):161–164. doi: 10.1016/0196-9781(85)90033-6. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES